PL2151241T3 - Trwały stały preparat zawierający pochodną 4,5-epoksymorfinanową - Google Patents
Trwały stały preparat zawierający pochodną 4,5-epoksymorfinanowąInfo
- Publication number
- PL2151241T3 PL2151241T3 PL08752145T PL08752145T PL2151241T3 PL 2151241 T3 PL2151241 T3 PL 2151241T3 PL 08752145 T PL08752145 T PL 08752145T PL 08752145 T PL08752145 T PL 08752145T PL 2151241 T3 PL2151241 T3 PL 2151241T3
- Authority
- PL
- Poland
- Prior art keywords
- solid preparation
- stable solid
- epoxymorphinan derivative
- effective ingredient
- epoxymorphinan
- Prior art date
Links
- QONGLMDHKNFCDX-KBHMWOLSSA-N (4r,4ar,12bs)-1,2,3,4,4a,5,6,7,7a,13-decahydro-4,12-methanobenzofuro[3,2-e]isoquinoline Chemical class O1C2CCC[C@H]3[C@]4([H])NCC[C@]23C2=C1C=CC=C2C4 QONGLMDHKNFCDX-KBHMWOLSSA-N 0.000 title abstract 3
- 239000007787 solid Substances 0.000 title abstract 3
- 239000004615 ingredient Substances 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 abstract 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 abstract 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 abstract 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 abstract 1
- 235000019345 sodium thiosulphate Nutrition 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 150000005846 sugar alcohols Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Epoxy Compounds (AREA)
- Epoxy Resins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007116721 | 2007-04-26 | ||
| PCT/JP2008/058111 WO2008133330A1 (ja) | 2007-04-26 | 2008-04-25 | ４，５－エポキシモルヒナン誘導体を含有する安定な固形製剤 |
| EP08752145A EP2151241B1 (en) | 2007-04-26 | 2008-04-25 | Stable solid preparation comprising 4,5-epoxymorphinan derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2151241T3 true PL2151241T3 (pl) | 2012-08-31 |
Family
ID=39925776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08752145T PL2151241T3 (pl) | 2007-04-26 | 2008-04-25 | Trwały stały preparat zawierający pochodną 4,5-epoksymorfinanową |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8420662B2 (pl) |
| EP (1) | EP2151241B1 (pl) |
| JP (2) | JP5099127B2 (pl) |
| KR (1) | KR101491656B1 (pl) |
| CN (1) | CN101686976B (pl) |
| AT (1) | ATE550023T1 (pl) |
| AU (1) | AU2008244936B2 (pl) |
| CA (1) | CA2685131C (pl) |
| DK (1) | DK2151241T3 (pl) |
| ES (1) | ES2381056T3 (pl) |
| MX (1) | MX2009011554A (pl) |
| PL (1) | PL2151241T3 (pl) |
| PT (1) | PT2151241E (pl) |
| WO (1) | WO2008133330A1 (pl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI455733B (zh) | 2009-03-30 | 2014-10-11 | Toray Industries | 口腔內崩壞性被覆錠劑 |
| US20130289060A1 (en) | 2010-10-19 | 2013-10-31 | Memorial Sloan-Kettering Cancer Center | 6-AMIDO DERIVATIVES OF 4, 5-a EPOXYMORPHINANS FOR THE TREATMENT OF PAIN |
| JP2013087170A (ja) * | 2011-10-17 | 2013-05-13 | Nippon Soda Co Ltd | ヒドロキシプロピルセルロース微粒子 |
| US10952968B2 (en) | 2012-05-14 | 2021-03-23 | Shionogi & Co., Ltd. | Preparation containing 6,7-unsaturated-7-carbamoyl morphinan derivatives |
| GB201318394D0 (en) * | 2013-10-17 | 2013-12-04 | Univ Edinburgh | Composition |
| EP3291676B1 (en) | 2015-04-30 | 2022-08-17 | Memorial Sloan Kettering Cancer Center | Mitragynine analogs and uses thereof |
| CN105461727A (zh) * | 2015-12-01 | 2016-04-06 | 吕涛 | 一种纳呋拉啡的精制方法 |
| CN119157840A (zh) | 2016-07-29 | 2024-12-20 | 东丽株式会社 | 光稳定性提高的固体制剂 |
| JP7153197B2 (ja) * | 2017-03-31 | 2022-10-14 | 東レ株式会社 | ナルフラフィンを含有する錠剤化された医薬組成物 |
| AU2019229892B2 (en) | 2018-03-08 | 2025-01-30 | University Of Kansas | Treatment of demyelinating diseases |
| WO2020205735A1 (en) | 2019-03-29 | 2020-10-08 | Humanwell Pharmaceutical US | Novel morphinans useful for treating medical disorders |
| PE20250155A1 (es) | 2021-06-14 | 2025-01-22 | Scorpion Therapeutics Inc | Derivados de la urea que pueden ser utilizados para tratar el cancer |
| EP4212149A1 (en) * | 2022-01-18 | 2023-07-19 | Rijksuniversiteit Groningen | Oral dosage forms of acid-labile salt and methods and uses related thereto |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8820327D0 (en) * | 1988-08-26 | 1988-09-28 | May & Baker Ltd | New compositions of matter |
| ES2121988T3 (es) | 1992-01-23 | 1998-12-16 | Toray Industries | Derivado de morfinano y uso medicinal. |
| WO1998023290A1 (en) * | 1996-11-25 | 1998-06-04 | Toray Industries, Inc. | Antipruritic agent |
| ES2141631T3 (es) | 1997-02-14 | 2000-03-16 | Goedecke Ag | Estabilizacion del hidrocloruro de naloxon. |
| TW580397B (en) * | 1997-05-27 | 2004-03-21 | Takeda Chemical Industries Ltd | Solid preparation |
| JP4939680B2 (ja) | 1997-05-27 | 2012-05-30 | 武田薬品工業株式会社 | 固形製剤 |
| DE69824277T2 (de) * | 1997-07-11 | 2004-09-23 | Toray Industries, Inc. | Stabile medizinische zusammenstellungen die 4,5-epoxymorphinanderivate enthalten |
| US6524568B2 (en) * | 1998-06-22 | 2003-02-25 | Cytomedix, Inc. | Enriched platelet wound healant |
| EP1133984B1 (en) * | 2000-03-17 | 2005-05-11 | Shin-Etsu Chemical Co., Ltd. | Solid preparation containing low-substituted hydroxypropyl cellulose and production process thereof |
| JP3698652B2 (ja) | 2000-03-17 | 2005-09-21 | 信越化学工業株式会社 | 低置換度ヒドロキシプロピルセルロース含有固形製剤及びその製造方法 |
| JP4802436B2 (ja) | 2000-04-12 | 2011-10-26 | Ｍｓｄ株式会社 | 口腔内崩壊型組成物及び口腔内崩壊型製剤 |
| JP3595765B2 (ja) * | 2000-09-27 | 2004-12-02 | 信越化学工業株式会社 | 低置換度ヒドロキシプロピルセルロースを含む乾式直打用基剤 |
| US20040121006A1 (en) * | 2001-03-06 | 2004-06-24 | Shoichi Narita | Utilization of spray-dried powder containing sugar alcohol |
| CN1652752A (zh) | 2002-03-14 | 2005-08-10 | 欧罗赛铁克股份有限公司 | 盐酸纳曲酮组合物 |
| JPWO2003103713A1 (ja) * | 2002-06-10 | 2005-10-06 | 大日本製薬株式会社 | 速崩壊性錠剤及びその製造方法 |
| ES2528631T3 (es) | 2003-04-08 | 2015-02-11 | Progenics Pharmaceuticals, Inc. | Formulaciones farmacéuticas que contienen metilnaltrexona |
-
2008
- 2008-04-25 PL PL08752145T patent/PL2151241T3/pl unknown
- 2008-04-25 US US12/597,475 patent/US8420662B2/en active Active
- 2008-04-25 KR KR20097021469A patent/KR101491656B1/ko active Active
- 2008-04-25 CN CN2008800136837A patent/CN101686976B/zh active Active
- 2008-04-25 WO PCT/JP2008/058111 patent/WO2008133330A1/ja not_active Ceased
- 2008-04-25 CA CA2685131A patent/CA2685131C/en active Active
- 2008-04-25 JP JP2009511919A patent/JP5099127B2/ja active Active
- 2008-04-25 EP EP08752145A patent/EP2151241B1/en active Active
- 2008-04-25 AT AT08752145T patent/ATE550023T1/de active
- 2008-04-25 PT PT08752145T patent/PT2151241E/pt unknown
- 2008-04-25 DK DK08752145.6T patent/DK2151241T3/da active
- 2008-04-25 AU AU2008244936A patent/AU2008244936B2/en active Active
- 2008-04-25 MX MX2009011554A patent/MX2009011554A/es active IP Right Grant
- 2008-04-25 ES ES08752145T patent/ES2381056T3/es active Active
-
2012
- 2012-06-27 JP JP2012144653A patent/JP5578199B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN101686976A (zh) | 2010-03-31 |
| JP5099127B2 (ja) | 2012-12-12 |
| CA2685131C (en) | 2015-05-19 |
| MX2009011554A (es) | 2010-01-25 |
| CA2685131A1 (en) | 2008-11-06 |
| PT2151241E (pt) | 2012-05-07 |
| KR20100015582A (ko) | 2010-02-12 |
| KR101491656B1 (ko) | 2015-02-09 |
| US8420662B2 (en) | 2013-04-16 |
| JPWO2008133330A1 (ja) | 2010-07-29 |
| US20100120815A1 (en) | 2010-05-13 |
| AU2008244936A1 (en) | 2008-11-06 |
| DK2151241T3 (da) | 2012-04-23 |
| CN101686976B (zh) | 2013-04-24 |
| JP5578199B2 (ja) | 2014-08-27 |
| WO2008133330A1 (ja) | 2008-11-06 |
| JP2012180382A (ja) | 2012-09-20 |
| AU2008244936B2 (en) | 2013-02-21 |
| EP2151241A1 (en) | 2010-02-10 |
| ATE550023T1 (de) | 2012-04-15 |
| EP2151241A4 (en) | 2010-06-02 |
| EP2151241B1 (en) | 2012-03-21 |
| ES2381056T3 (es) | 2012-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2151241T3 (pl) | Trwały stały preparat zawierający pochodną 4,5-epoksymorfinanową | |
| MY151295A (en) | Pyrimidyl indoline compound | |
| WO2011003853A3 (en) | Process for drying of bibw2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient | |
| MA32604B1 (fr) | Composes organiques | |
| MX2011011175A (es) | Coposiciones herbicidas de alta concentracion de las sales de glifosato y de 2,4-d. | |
| TNSN08505A1 (fr) | Compositions pharmaceutiques stabilisees comprenant de la fesoterodine | |
| WO2012048129A3 (en) | Inhibitors of polo-like kinase | |
| ATE520406T1 (de) | Kristalline form des ibandronat-natriums | |
| WO2011003673A3 (de) | Kosmetische zusammensetzungen mit suspensionen von silbersalzen | |
| FI3817751T3 (fi) | Vedettömän natriumtiosulfaatin formulaatioita | |
| WO2008062476A3 (en) | Pharmaceutical composition comprising rosuvastatin or pharmaceutically accepatble salts thereof | |
| IN2015DN02751A (pl) | ||
| WO2010091827A3 (de) | Kosmetische zubereitung zur hautpflege | |
| EA201300715A1 (ru) | Бульонный кубик | |
| UA99146C2 (ru) | Сокристаллы пириметанила и дитианона, способы их получения (варианты), композиция, содержащая их, и ее применение, водный суспензионный концентрат и способы его получения (варианты) | |
| TN2010000585A1 (en) | Pharmaceutical compositions of rosuvastatin calcium | |
| MX2009007038A (es) | Derivados de mononitrato de isosorbida para el tratamiento de trastornos intestinales. | |
| TW200616647A (en) | Progression inhibitor for disease attributed to abnormal accumulation of liver fat | |
| WO2005110413A3 (en) | Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions | |
| WO2007138462A3 (en) | Aqueous oral formulations of risperidone | |
| MX2009005182A (es) | Derivados de 2-hidroxi-1,3-diamino-propano. | |
| ZA200705949B (en) | Fabric conditioning compositions | |
| MX2009012841A (es) | Nuevos derivados del acido 3-fenil propanoico que son activadores de los receptores del tipo del receptor activado por el proliferador de peroxisoma, su metodo de preparacion y su uso en composiciones cosmeticas o farmaceuticas. | |
| TW201129660A (en) | Dermal absorption agent comprising felbinac | |
| UA103544C2 (uk) | Кристалічна форма і цинкової солі розувастатину |